These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31129650)

  • 21. Elimination of KLK5 inhibits early skin tumorigenesis by reducing epidermal proteolysis and reinforcing epidermal microstructure.
    Pampalakis G; Zingkou E; Kaklamanis L; Spella M; Stathopoulos GT; Sotiropoulou G
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165520. PubMed ID: 31381994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caesalpinia sappan: A promising natural source of antimicrobial agent for inhibition of cariogenic bacteria.
    Puttipan R; Chansakaow S; Khongkhunthian S; Okonogi S
    Drug Discov Ther; 2018; 12(4):197-205. PubMed ID: 30224592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiinflammatory and Wound Healing Effects of Caesalpinia sappan L.
    Tewtrakul S; Tungcharoen P; Sudsai T; Karalai C; Ponglimanont C; Yodsaoue O
    Phytother Res; 2015 Jun; 29(6):850-6. PubMed ID: 25760294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets.
    Di Paolo CT; Diamandis EP; Prassas I
    Crit Rev Clin Lab Sci; 2021 Jan; 58(1):1-16. PubMed ID: 32568598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.
    Walker AL; Denis A; Bingham RP; Bouillot A; Edgar EV; Ferrie A; Holmes DS; Laroze A; Liddle J; Fouchet MH; Moquette A; Nassau P; Pearce AC; Polyakova O; Smith KJ; Thomas P; Thorpe JH; Trottet L; Wang Y; Hovnanian A
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126675. PubMed ID: 31521475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward the first class of suicide inhibitors of kallikreins involved in skin diseases.
    Tan X; Soualmia F; Furio L; Renard JF; Kempen I; Qin L; Pagano M; Pirotte B; El Amri C; Hovnanian A; Reboud-Ravaux M
    J Med Chem; 2015 Jan; 58(2):598-612. PubMed ID: 25489658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme oxygenase-1 mediates the inhibitory actions of brazilin in RAW264.7 macrophages stimulated with lipopolysaccharide.
    Hu CM; Liu YH; Cheah KP; Li JS; Lam CS; Yu WY; Choy CS
    J Ethnopharmacol; 2009 Jan; 121(1):79-85. PubMed ID: 18983903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel inhibitory activity for serine protease inhibitor Kazal type-3 (Spink3) on human recombinant kallikreins.
    Assis DM; Zalazar L; Juliano MA; De Castro R; Cesari A
    Protein Pept Lett; 2013 Oct; 20(10):1098-107. PubMed ID: 23590280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like Synoviocytes.
    Lee H; Kang SW; Byun HS; Jeon J; Park KA; Kang K; Seo W; Won M; Seok JH; Han MD; Shen HM; Hur GM
    PLoS One; 2015; 10(8):e0136122. PubMed ID: 26295477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brazilin and the extract from Caesalpinia sappan L. protect oxidative injury through the expression of heme oxygenase-1.
    Choi BM; Lee JA; Gao SS; Eun SY; Kim YS; Ryu SY; Choi YH; Park R; Kwon DY; Kim BR
    Biofactors; 2007; 30(3):149-57. PubMed ID: 18525109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brazilin selectively disrupts proximal IL-1 receptor signaling complex formation by targeting an IKK-upstream signaling components.
    Jeon J; Lee JH; Park KA; Byun HS; Lee H; Lee Y; Zhang T; Kang K; Seok JH; Kwon HJ; Han MD; Kang SW; Hong JH; Hur GM
    Biochem Pharmacol; 2014 Jun; 89(4):515-25. PubMed ID: 24735611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of Caesalpinia sappan L. heartwood extraction procedure to obtain the highest content of brazilin and greatest antibacterial activity.
    Settharaksa S; Monton C; Charoenchai L
    J Integr Med; 2019 Sep; 17(5):351-358. PubMed ID: 31130448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
    Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
    Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Propionibacterium acnes assay-guided purification of brazilin and preparation of brazilin rich extract from Caesalpinia sappan heartwood.
    Nirmal NP; Panichayupakaranant P
    Pharm Biol; 2014 Sep; 52(9):1204-7. PubMed ID: 24963948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein-related Peptidase 5 (KLK5) Expression and Distribution in Canine Cutaneous Squamous Cell Carcinoma.
    Ortloff A; Bustamante FA; Molina L; Ojeda J; Figueroa CD; Ehrenfeld P
    J Comp Pathol; 2020 Jan; 174():113-119. PubMed ID: 31955796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review.
    Nirmal NP; Rajput MS; Prasad RG; Ahmad M
    Asian Pac J Trop Med; 2015 Jun; 8(6):421-30. PubMed ID: 26194825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthma.
    Jackman JK; Stockwell A; Choy DF; Xie MM; Lu P; Jia G; Li H; Abbas AR; Bronson PG; Lin WY; Chiu CPC; Maun HR; Roose-Girma M; Tam L; Zhang J; Modrusan Z; Graham RR; Behrens TW; White SR; Naureckas T; Ober C; Ferreira M; Sedlacek R; Wu J; Lee WP; Lazarus RA; Koerber JT; Arron JR; Yaspan BL; Yi T
    J Allergy Clin Immunol; 2022 Oct; 150(4):972-978.e7. PubMed ID: 35487308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.
    Brattsand M; Stefansson K; Hubiche T; Nilsson SK; Egelrud T
    J Invest Dermatol; 2009 Jul; 129(7):1656-65. PubMed ID: 19194479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.